Navigation Links
Night Time Aspirin Regimen Found to Reduce Blood Pressure

Patients with mild hypertension experienced a significant reduction in blood pressure as the result of regularly taking aspirin before bed, according to a new study.
To investigate the effect of aspirin taken at different times of the rest-activity cycle, Ramon C. Hermida, Ph.D., of Bioengineering and Chronobiology Laboratories, University of Vigo, Campus Universitario, Spain, and colleagues studied a group of 100 volunteers with untreated mild essential hypertension. //
Study participants included 34 men and 66 women, ages 23 to 79 years. The entire group received nonpharmacological hygienic-dietary recommendations, including regular aerobic exercise, restrictions on sodium and alcohol consumption, and information on the Dietary Approach to Stop Hypertension Diet.

Researchers randomly assigned participants to 3 subgroups, which received a regimen of no aspirin, 100 mg aspirin after waking, or 100 mg aspirin before sleeping. Evaluation by blood pressure monitoring occurred for 48 consecutive hours for all participants at baseline and after completion of three-months of their prescribed regimen. Each participant received an ambulatory monitoring device during the monitoring periods. Automatic measurements for systolic blood pressure, mean arterial blood pressure, diastolic blood pressure, and heart rate occurred every 20 minutes between 7:00 a.m. and 11:00 p.m., and every 30 minutes at night.

No significant differences existed between subgroups for blood pressure or heart rate at baseline. However, researchers noted highly significant changes to blood pressure between groups after the 3-month treatment period. The subgroup following a regimen of evening aspirin administration showed a reduction in the 24 hour mean of 6.2 mm Hg in systolic blood pressure and 4.1 mm Hg in diastolic blood pressure. While 85% of this subgroup experienced a reduction of blood pressure, the effect was not evident for the subgroups receiving no asp
'"/>




Page: 1 2

Related medicine news :

1. Night borns risk
2. Nightlights could ward diabetic blindness
3. Exposure To Night Light may Increase The Risk Of Leukemia
4. Understanding The Mystery Behind Sleepless Nights
5. Neonatal Risk Of Death Is More For Babies Born At Night
6. Night Light Found To Increase The Risk Of Leukemia
7. Drug Trial Turned Into a Terrible Nightmare
8. Secret Herb Could Tackle Hot Flushes And Night Sweats In Breast Cancer Patients
9. Melatonin Can Help Nighttime Workers Sleep
10. Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure
11. Drug Trial Proves Nightmare for British Indian Student
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...bstetrical anesthesia, whether provided by Certifi...esiologists, is extremely safe//. There is no diff...RNAs compared with those that use only anesthesiol...e study, titled "Anesthesia Staffing and Anestheti...
... new method in ultrasound known as "eSie Touch Ela...Solutions at the ECR 2007 (European Congress of Ra...t this new method, which is an adjunct to regular ...nically relevant differentiation of benign and mal...
...ew research from the University of North Carolina ...wo proteins that may help protect against skin can...line edition of the journal Molecular and Cellular..., named Timeless and Tipin, form a complex that re...
...hubaneswar: Scientists in Orissa have developed a ...others and is bacteria resistant.// A team of scie...ect three years ago to develop a variety of fish t...cterial disease affecting hatcheries in India, Pra...
Other Medicine News:Health News:Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists 2Health News:eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies 2Health News:Researchers Discover Proteins That Protect Against Skin Cancer 2Health News:Scientists Develop Bacteria-resistant Fish 2
(Date:8/17/2008)...Aug. 17 /Xinhua-- Pharmaxis... first pivotal Phase 3,clinical trial of Bronchito...ed enrolment., The first efficacy data from the t...half of 2009. The trial commenced its dosing phase...rget of 250 subjects in June,2008 and closed today...
(Date:8/14/2008)...g. 14 /- Pharmasset, Inc.,(...ompany committed to,discovering, developing and co...s, reported unaudited financial results for the th... reported a net loss attributable to,common stockh....69 for the,quarter ended June 30, 2008, as compar...
(Date:8/14/2008)...pment to begin in late 2008 or in early 2009 -, S...-- Nuvelo, Inc.,(Nasdaq: NUVO ) today announced p... trial of NU172, demonstrating that the direct thr...ticoagulation with a rapid,return toward baseline ...rofile., "NU172 has the potential to address many...
(Date:8/13/2008)...hid Pharma partners with Diakron, MORRIS PLAINS, ...als,Inc. announced today the signing of an exclus...oral anticoagulant drug candidate discovered and,d...& Co. Inc. Under the,terms of the agreement, Diakr...proved, market and distribute the compound worldwi...
Breaking Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc. 2America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 1America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 2America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 3America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 4WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 1WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 2WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 3Nanotechnology 3A Whats that 3F 244 1Nanotechnology 3A Whats that 3F 244 2The aye ayes have it 3A The preservation of color vision in a creature of the night 445 1The aye ayes have it 3A The preservation of color vision in a creature of the night 445 2The aye ayes have it 3A The preservation of color vision in a creature of the night 445 3
...SS WIRE)--Jun 25, 2007 - Gilead,Sciences, Inc. (Na... III clinical trial evaluating the company,s once-...l fumarate or tenofovir,DF) 300 mg as a potential ...ction, met its primary efficacy endpoint. The data... once-daily antiviral,drug Hepsera(R) (adefovir di...
... WIRE)--Jun 25, 2007 - Affymax, Inc.,(Nasdaq:AFFY)...trial results for Hematide(TM) were presented at t...held in Barcelona, Spain by Iain C.,Macdougall, M....ndon. Dr. Macdougall,s poster included data in pre...ive, non-dialysis patients which,demonstrated that...
Other Medicine Technology:Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia 2Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia 3
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: